Status
Conditions
About
The aim of this phase 4 study is to evaluate the safety profile of ONIVYDE in China mainland.
Primary objective
To characterize the safety of ONIVYDE when used under standard clinical practice in China mainland on the following aspects:
(1) Overall survival (2) Overall response (3) Progression free survival (4) Quality of life assessment
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
120 participants in 1 patient group
Loading...
Central trial contact
Qiaohui KANG Sr.PM
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal